ArticleIJID regions2026
Survival analysis and mortality predictors of COVID-19 in Moroccan children: A multicenter study.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Although COVID-19 in children is benign, it has revealed a critical vulnerability in the neonatal population. This study aimed to identify the mortality predictors and determinants of survival in children affected by COVID-19 in the Marrakech-Safi (RMS) region of Morocco. Methods: This was a retrospective, multicenter cohort study conducted among children hospitalized with COVID-19 between March 2020 and December 2021 in two RMS hospitals. All patients aged under 15 years with confirmed SARS-CoV-2 infection were included; incomplete files, misdiagnoses, and transferred patients were excluded. Overall survival was assessed using the Kaplan-Meier curve, associations were examined with the log-rank test, and predictors were identified using Cox proportional hazards regression models. Results: A total of 167 children were identified, including 52.7% females and 20.4% (n = 34) neonates. The death rate was 4.79%, with a mean overall survival of 40.9 days. The analysis identified thrombocytopenia (adjusted hazard ratio [aHR] = 87.07, 95% confidence interval [CI]: 59.85-126.77, Conclusion: Implementing rapid intervention and preventive medicine strategies is essential to reducing morbidity and mortality in pediatric populations during future public health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.